Top Markets
#1 GEKKO GEKKO +52.86%
#2 Helium Helium +45.40%
#3 Pons Pons +21.76%
#4 Main Street Yield Main Street Yield +17.48%
#5 龙虾 (Lobster) 龙虾 (Lobster) +16.03%
#6 Collect on Fanable Collect on Fanable +14.73%
#7 Cysic Cysic +13.73%
#8 Ontology Gas Ontology Gas +13.53%
#9 o1.exchange o1.exchange +13.31%
#10 OpenGradient OpenGradient +11.75%
Coin of the day
GEKKO GEKKO
설정
언어
한국어
통화
USD
테마
New Journey Health Technology Group Co.,LTD New Journey Health Technology Group Co.,LTD

New Journey Health Technology Group Co.,LTD

002219
주식 순위 #8926
This company maintains a diverse business portfolio, encompassing the provision... This company maintains a diverse business portfolio, encompassing the provision of medical services, pharmaceutical manufacturing, and the distribution of daily chemical and wellness products. Its pharmaceutical production includes various dosage forms such as tablets, syrups, capsules, mixtures, and pills. The enterprise was established on September 30, 2001, with its primary office situated in Beijing, China.
주가
$0.32895452
마지막 동기화: 2026-08-28
시가총액
$1.14B
변동 (1일)
-0.44%
변동 (1년)
8.60%
국가
CN
거래 New Journey Health Technology Group Co.,LTD (002219)

카테고리

Healthcare
New Journey Health Technology Group Co.,LTD (002219)의 P/B 비율
2026 기준 P/B 비율 TTM: 0
New Journey Health Technology Group Co.,LTD의 최신 재무 보고서와 주가에 따르면 현재 P/B 비율(TTM)은 0입니다. 2026년 말 기준 P/B 비율은 0였습니다.
New Journey Health Technology Group Co.,LTD의 P/B 비율 기록 (2026 ~ 2026)
매년 말 P/B 비율
연도 P/B 비율 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 P/B 비율
회사 P/B 비율 P/B 비율 차이 국가
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 3.817 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
 2.4038 -
HK
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT